07/15/2019 03:31 PM EDT |
 |
Neuro-oncologist Mark Gilbert, M.D., shares how molecular testing is enabling researchers to find more precise treatments for brain and spine tumors. These treatments include immunotherapy and synthetic lethality. Learn more: www.cancer.gov/nci/rare-brain- |
No hay comentarios:
Publicar un comentario